Cerebrolysin

uestion": "What is Cerebrolysin made from?", "answer": "Cerebrolysin is a peptide preparation derived from the enzymatic breakdown of purified porcine (pig) brain proteins. It contains a mixture of biologically active neuropeptides."}, {"question": "Is Cerebrolysin approved universally by health authorities?", "answer": "No, Cerebrolysin's regulatory status varies significantly by country. It is approved and widely used in some regions, particularly in Eastern Europe and Asia, for neurological conditions. However, it is not approved by agencies like the U.S. FDA, which cites insufficient evidence based on their standards."}, {"question": "How is Cerebrolysin administered?", "answer": "Cerebrolysin is an injectable solution. It can be administered intravenously (IV) as a slow infusion or intramuscularly (IM), depending on the prescribed dose and clinical context. Administration should always be performed by a qualified healthcare professional."}, {"question": "Can Cerebrolysin be taken orally?", "answer": "No, Cerebrolysin is not available as an oral formulation because its peptide components would likely be broken down by digestive enzymes before they could be absorbed and become active. It must be administered parenterally (by injection)."}, {"question": "What are the main potential uses of Cerebrolysin?", "answer": "Cerebrolysin is primarily investigated and used for various neurological conditions, including acute ischemic stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer's disease and vascular dementia, with the aim of promoting neuroprotection and recovery."}]